KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Depreciation & Amortization (CF) (2016 - 2026)

Eli Lilly filings provide 18 years of Depreciation & Amortization (CF) readings, the most recent being $509.0 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 9.94% to $509.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.0 billion, a 11.69% increase, with the full-year FY2025 number at $2.0 billion, up 13.02% from a year prior.
  • Depreciation & Amortization (CF) hit $509.0 million in Q1 2026 for Eli Lilly, down from $585.7 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $585.7 million in Q4 2025 to a low of $348.9 million in Q2 2022.
  • Median Depreciation & Amortization (CF) over the past 5 years was $414.4 million (2024), compared with a mean of $430.7 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): fell 16.85% in 2023 and later increased 25.25% in 2024.
  • Eli Lilly's Depreciation & Amortization (CF) stood at $375.0 million in 2022, then grew by 3.31% to $387.4 million in 2023, then rose by 25.25% to $485.2 million in 2024, then grew by 20.71% to $585.7 million in 2025, then fell by 13.1% to $509.0 million in 2026.
  • The last three reported values for Depreciation & Amortization (CF) were $509.0 million (Q1 2026), $585.7 million (Q4 2025), and $470.0 million (Q3 2025) per Business Quant data.